General
Pembrolizumab, previously approved for various types of cancer diseases, has been approved for use in patients with hepatocellular carcinoma. Immunotherapies…
Skin cancer (CSCC type) can now be treated with Libtayo (cemiplimab) in the United States. Cemiplimab enables the activity of…
On 29 August 2018 US federal agency accepted the clinical use of biopharmaceutical JIVI produced by Bayer HealthCare LLC. Adult…